Join NCBIO members for lunch and a panel on the changing landscape in clinical research and clinical trials.
- Rose Blackburne, M.D., vice president, global product development, PPD, part of Thermo Fisher Scientific
- Erin Finot, vice president, immuno-oncology and cell and gene therapy, IQVIA Biotech
- Julie Harrell, director, patient enrollment liaisons, Ultragenyx
- Josh Sommer, executive director, Chordoma Foundation
Panelists will address the barriers and challenges to diversity in clinical trials and patient recruitment and will look at rare disease considerations. The role of patient advocates in clinical research and clinical trials will also be discussed.
Thank you to Sikich, Ultragenyx and uMotif for sponsoring this forum.